NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 177 filers reported holding NEKTAR THERAPEUTICS in Q1 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $618,000 | -87.7% | 26,700 | -67.5% | 0.06% | -89.3% |
| Q3 2018 | $5,015,000 | +39.5% | 82,263 | +11.7% | 0.53% | +32.3% |
| Q2 2018 | $3,595,000 | -65.8% | 73,614 | -25.6% | 0.40% | -65.1% |
| Q1 2018 | $10,511,000 | +49.4% | 98,914 | -16.0% | 1.15% | +31.1% |
| Q4 2017 | $7,036,000 | +3920.6% | 117,815 | +823.3% | 0.88% | +10887.5% |
| Q1 2016 | $175,000 | -92.4% | 12,760 | -90.7% | 0.01% | -91.9% |
| Q4 2015 | $2,311,000 | +102.0% | 137,127 | +31.3% | 0.10% | +90.4% |
| Q3 2015 | $1,144,000 | -8.4% | 104,399 | +4.6% | 0.05% | 0.0% |
| Q2 2015 | $1,249,000 | +43.6% | 99,852 | +26.2% | 0.05% | +57.6% |
| Q1 2015 | $870,000 | – | 79,115 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |